a.ilunga
TL2 Moderator · Angers
Contributes reviews on supplier material. Based in Angers.
Joined 1 June 2025 · last posted 4d
85 posts, newest first. Showing up to 150.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #99 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 0 likes post #98 answers the question as asked. The question underneath it is different. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per…
-
Immortal time bias in a claims-database study — one year on Replied, post #35 · Evidence › Study critique · 21 Jul 2026 · 1 like What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Seven-day rolling means and why weekly readings mislead Replied, post #57 · Outcomes › Progress reports · 18 Jul 2026 · 2 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
A site rotation scheme that is easy enough to actually follow Replied, post #118 · Practice › Administration · 18 Jul 2026 · 31 likes I read post #116 twice before replying, because I had assumed the opposite. Cold solution and stinging: warming the vial in your hands for a minute before injection…
-
Programming during a large energy deficit Replied, post #42 · Nutrition & Training › Resistance training · 17 Jul 2026 · 16 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
What to bring: records that a clinician can actually use Replied, post #4 · marked as the solution · Clinical › Prescriber conversations · 16 Jul 2026 · 25 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #40 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #11 · Analytics › Impurities & related substances · 14 Jul 2026 · 1 like Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #64 · Evidence › Journal club · 12 Jul 2026 · 9 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Follow-up: UK access routes, dated and sourced Replied, post #11 · Regional › UK & Ireland · 12 Jul 2026 · 15 likes Worth separating two things that post #7 runs together. Importing for personal use: importing a prescription-only medicine without a prescription is not lawful.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #42 · Analytics › Home & field testing · 1 Jul 2026 · 0 likes Picking up post #39: that is the part I would want checked first. What physical quantity does the device measure? A colorimetric or lateral-flow method typically…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #69 · Compounds › Tirzepatide · 29 Jun 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #76 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 0 likes I read post #74 twice before replying, because I had assumed the opposite. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
-
A site rotation scheme that is easy enough to actually follow Replied, post #98 · Practice › Administration · 26 Jun 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #21 · Analytics › Impurities & related substances · 24 Jun 2026 · 1 like Coming back to post #19, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #28 · Compounds › Secretagogues & GH axis · 22 Jun 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #122 · Practice › Reconstitution · 21 Jun 2026 · 4 likes Picking up post #119: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Revisiting: What pooling buys you and what it destroys Replied, post #55 · Evidence › Meta-analyses · 15 Jun 2026 · 0 likes Worth separating two things that post #51 runs together. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or…
-
Injecting into an area that has become firm: why not to Replied, post #6 · Practice › Administration · 2 Jun 2026 · 22 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
What to include when your question involves a chromatogram — one year on Replied, post #21 · Start Here › How to Ask · 31 May 2026 · 13 likes post #20 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #65 · Compounds › Tirzepatide · 19 May 2026 · 31 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
The most useful thing you learned here that was not the answer you came for Replied, post #38 · Lounge › Off topic · 28 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #49 · Practice › Interactions · 25 Apr 2026 · 23 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #31 · Compounds › Repair & healing peptides · 2 Apr 2026 · 3 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #5 · Compounds › Oral incretins · 28 Mar 2026 · 1 like Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #33 · Practice › Administration · 19 Mar 2026 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
The "under review" status pill and when a moderator applies it Replied, post #22 · Evidence › Preprints · 16 Mar 2026 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #38 · Practice › Administration · 15 Mar 2026 · 16 likes I read post #36 twice before replying, because I had assumed the opposite. Drawing up with one needle and injecting with another: a reasonable practice if you have…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #19 · Compounds › Repair & healing peptides · 9 Mar 2026 · 15 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #60 · Practice › Interactions · 4 Mar 2026 · 13 likes post #59 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #11 · Meta › Announcements · 2 Mar 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #116 · Practice › Dosing & titration · 21 Feb 2026 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Time to steady state after a dose increase Replied, post #3 · Pharmacology › Pharmacokinetics · 18 Feb 2026 · 8 likes I read the opening post twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #28 · Compounds › Semaglutide · 15 Feb 2026 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #75 · Pharmacology › Pharmacokinetics · 4 Feb 2026 · 0 likes post #74 answers the question as asked. The question underneath it is different. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…
-
Revisiting: Absolute versus relative contraindications Replied, post #13 · Safety › Contraindications · 24 Jan 2026 · 0 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Guidelines revision: what changed and why — one year on Replied, post #61 · Meta › Announcements · 22 Jan 2026 · 0 likes post #60 answers the question as asked. The question underneath it is different. Implementation timeline: announcements include when a change takes effect. Marking the…
-
Coming back to: Pen dose counters: what a click does and does not guarantee Replied, post #3 · Devices › Pens & autoinjectors · 8 Jan 2026 · 13 likes On the opening post — agreed on the reasoning, with one qualification. Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push…
-
Prescription requirements and telehealth models Replied, post #84 · Sourcing › Regulatory · 22 Dec 2025 · 0 likes post #83 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
-
Early satiety becoming a problem rather than a benefit Replied, post #17 · Practice › Side effects · 18 Dec 2025 · 3 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Reading U-100 graduations, with a conversion table — one year on Started this topic · Devices › Syringes & needles · 11 Dec 2025 · 47 likes Reading U-100 graduations, with a conversion table — one year on Writing it up because I had to work it out twice and would rather nobody else did. Practical question…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #24 · Research Methods › N-of-1 designs · 3 Dec 2025 · 1 like Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #26 · Access › Pricing · 29 Nov 2025 · 0 likes post #25 answers the question as asked. The question underneath it is different. Compute cost per delivered dose at your dose if you want a number you can act on. That…
-
Robustness: the parameters worth deliberately varying Replied, post #20 · Analytics › Method validation · 25 Nov 2025 · 0 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
What pooling buys you and what it destroys Replied, post #67 · Evidence › Meta-analyses · 15 Nov 2025 · 23 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Reading SURMOUNT-1 without the press release Replied, post #56 · Compounds › Tirzepatide · 5 Nov 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading an interaction checker output critically Replied, post #20 · Practice › Interactions · 11 Oct 2025 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Follow-up: Why appetite effects are mostly central Replied, post #60 · Pharmacology › Receptor biology · 7 Oct 2025 · 0 likes post #59 answers the question as asked. The question underneath it is different. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #58 · Compounds › Other compounds · 29 Sep 2025 · 7 likes Picking up post #55: that is the part I would want checked first. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #103 · Compounds › Oral incretins · 17 Sep 2025 · 0 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #93 · Data & Tools › Datasets · 10 Sep 2025 · 19 likes post #92 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reading SURMOUNT-1 without the press release Replied, post #3 · Compounds › Tirzepatide · 5 Sep 2025 · 9 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
What this community means by "a source", in practical terms Replied, post #89 · Start Here › Welcome · 28 Aug 2025 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
When a preprint is the best available evidence and we say so Replied, post #64 · Evidence › Preprints · 16 Aug 2025 · 3 likes On post #60 — agreed on the reasoning, with one qualification. Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly.…
-
A ten-fold dose error caught before injection — one year on Replied, post #130 · Devices › Syringes & needles · 4 Aug 2025 · 20 likes post #129 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
EU-wide position versus national implementation Replied, post #20 · Regional › European Union · 24 Jul 2025 · 0 likes Worth separating two things that post #16 runs together. Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions.…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #47 · Data & Tools › Calculators · 10 Jul 2025 · 32 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #150 · Practice › Reconstitution · 30 Jun 2025 · 16 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Why the timeline is on the right and not the left Replied, post #34 · Meta › Site feedback · 28 Jun 2025 · 0 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #39 · Pharmacology › Pharmacokinetics · 10 Jun 2025 · 16 likes Coming back to post #37, because the follow-up matters more than the original answer. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino)…
-
Regression to the mean in progress reports Replied, post #16 · Research Methods › Statistics · 3 Jun 2025 · 1 like post #15 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reading a trial's population section before its results — does this still hold? Replied, post #135 · Evidence › Trials · 23 May 2025 · 15 likes On post #131 — agreed on the reasoning, with one qualification. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm…
-
Travel coolers and how long they really hold — the long version Replied, post #6 · Devices › Cold chain · 19 May 2025 · 2 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #29 · Evidence › Trials · 13 May 2025 · 0 likes I read post #27 twice before replying, because I had assumed the opposite. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
-
Relative retention time as a better inter-laboratory comparator Replied, post #6 · Analytics › Method validation · 2 May 2025 · 29 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #47 · Analytics › Mass spectrometry · 27 Mar 2025 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #78 · Evidence › Journal club · 16 Mar 2025 · 2 likes On post #74 — agreed on the reasoning, with one qualification. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
Follow-up: What other technical communities get right that we do not Replied, post #32 · Lounge › Off topic · 6 Mar 2025 · 17 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Protein density versus volume when you cannot eat much Replied, post #47 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 19 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #27 · Practice › Reconstitution · 30 Jan 2025 · 26 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Canadian access and provincial variation Replied, post #20 · Regional › North America · 25 Jan 2025 · 26 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Recovery when intake is low: what to cut first Replied, post #61 · Nutrition & Training › Resistance training · 13 Jan 2025 · 4 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
When to suspect the method rather than the sample Replied, post #65 · Analytics › Method validation · 13 Jan 2025 · 32 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #153 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #73 · Compounds › Semaglutide · 23 Dec 2024 · 1 like The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #157 · Analytics › COA interpretation · 19 Dec 2024 · 8 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #71 · Access › Insurance & coverage · 15 Dec 2024 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #39 · Practice › Side effects · 1 Dec 2024 · 25 likes Picking up post #36: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #17 · Clinical › Special populations · 20 Nov 2024 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
EMA product information as a primary source — does this still hold? Replied, post #61 · Regional › European Union · 16 Nov 2024 · 11 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #21 · Compounds › Semaglutide · 11 Nov 2024 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why "any advice?" is the least effective ending for a post Replied, post #14 · Start Here › How to Ask · 6 Nov 2024 · 26 likes On post #10 — agreed on the reasoning, with one qualification. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #18 · Sourcing › Regulatory · 1 Nov 2024 · 3 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Reporting a discrepancy without making an allegation Replied, post #49 · Sourcing › Vendor reports · 30 Aug 2024 · 0 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #4 · Evidence › Journal club · 6 Jul 2024 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…